GOCO
Income statement / Annual
Last year (2025), GoHealth Inc's total revenue was $361.85 M,
a decrease of 54.71% from the previous year.
In 2025, GoHealth Inc's net income was -$257.13 M.
See GoHealth Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$361.85 M |
$798.89 M |
$734.67 M |
$631.68 M |
$1.06 B |
$877.35 M |
$539.50 M |
$226.21 M |
| Cost of Revenue |
$96.13 M
|
$130.61 M
|
$158.96 M
|
$187.67 M
|
$239.34 M
|
$199.20 M
|
$169.55 M
|
$79.58 M
|
| Gross Profit |
$265.72 M
|
$668.28 M
|
$575.71 M
|
$444.01 M
|
$823.08 M
|
$678.15 M
|
$369.95 M
|
$146.62 M
|
| Gross Profit Ratio |
0.73
|
0.84
|
0.78
|
0.7
|
0.77
|
0.77
|
0.69
|
0.65
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$46.32 M
|
$16.20 M
|
| General & Administrative Expenses |
$90.79 M
|
$82.12 M
|
$93.07 M
|
$116.53 M
|
$98.18 M
|
$197.23 M
|
$92.89 M
|
$27.46 M
|
| Selling & Marketing Expenses |
$116.38 M
|
$235.70 M
|
$205.04 M
|
$207.56 M
|
$365.14 M
|
$206.86 M
|
$156.09 M
|
$28.13 M
|
| Selling, General & Administrative Expenses |
$207.17 M
|
$317.81 M
|
$298.11 M
|
$324.09 M
|
$463.32 M
|
$404.09 M
|
$248.98 M
|
$55.59 M
|
| Other Expenses |
$211.49 M
|
$357.52 M
|
$359.28 M
|
$438.58 M
|
$849.20 M
|
$338.60 M
|
$107.43 M
|
$46.08 M
|
| Operating Expenses |
$418.66 M
|
$675.33 M
|
$657.39 M
|
$762.67 M
|
$1.31 B
|
$742.69 M
|
$402.73 M
|
$117.86 M
|
| Cost And Expenses |
$514.79 M
|
$805.94 M
|
$816.35 M
|
$950.34 M
|
$1.55 B
|
$941.90 M
|
$572.28 M
|
$197.44 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$87.32 M
|
$72.87 M
|
$69.47 M
|
$57.07 M
|
$33.51 M
|
$32.97 M
|
$8.22 M
|
$224.00 K
|
| Depreciation & Amortization |
$80.11 M
|
$105.89 M
|
$105.75 M
|
$107.00 M
|
$107.51 M
|
$98.55 M
|
$29.89 M
|
$6.16 M
|
| EBITDA |
-$333.66 M |
$173.71 M |
$24.10 M |
-$211.55 M |
-$393.21 M |
$34.36 M |
$76.32 M |
$34.54 M |
| EBITDA Ratio |
-0.92
|
0.22
|
0.03
|
-0.33
|
-0.37
|
0.04
|
0.14
|
0.15
|
| Operating Income Ratio |
-0.42
|
-0.01
|
-0.11
|
-0.5
|
-0.46
|
-0.07
|
-0.06
|
0.13
|
| Total Other Income/Expenses Net |
-$348.15 M
|
$2.00 M
|
-$69.44 M
|
-$56.95 M
|
-$44.77 M
|
-$32.61 M
|
-$8.31 M
|
-$603.00 K
|
| Income Before Tax |
-$501.09 M
|
-$5.05 M
|
-$151.12 M
|
-$375.62 M
|
-$534.22 M
|
-$97.16 M
|
$41.09 M
|
$28.16 M
|
| Income Before Tax Ratio |
-1.38
|
-0.01
|
-0.21
|
-0.59
|
-0.5
|
-0.11
|
0.08
|
0.12
|
| Income Tax Expense |
-$3.34 M
|
$2.27 M
|
$154.00 K
|
$764.00 K
|
-$24.00 K
|
$43.00 K
|
$22.00 K
|
$46.00 K
|
| Net Income |
-$257.13 M
|
-$2.93 M
|
-$63.26 M
|
-$148.71 M
|
-$189.36 M
|
-$44.27 M
|
-$41.07 M
|
$28.12 M
|
| Net Income Ratio |
-0.71
|
-0
|
-0.09
|
-0.24
|
-0.18
|
-0.05
|
-0.08
|
0.12
|
| EPS |
-20.17 |
-0.66 |
-7.19 |
-17.72 |
-26.85 |
-3.3 |
-1.96 |
1.34 |
| EPS Diluted |
-20.17 |
-0.66 |
-7.19 |
-17.72 |
-26.85 |
-3.3 |
-1.96 |
1.34 |
| Weighted Average Shares Out |
$12.94 M
|
$9.98 M
|
$9.29 M
|
$8.45 M
|
$7.07 M
|
$5.61 M
|
$20.91 M
|
$20.91 M
|
| Weighted Average Shares Out Diluted |
$12.94 M
|
$9.98 M
|
$9.29 M
|
$8.45 M
|
$7.07 M
|
$5.61 M
|
$20.91 M
|
$20.91 M
|
| Link |
|
|
|
|
|
|
|
|
